KAL-671

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameKAL-671
Drug Alias Name2-methyl-oleoyl serineoleoyl alpha-methyl-serineoleoyl serineacyl amides (Hebrew University of Jerusalem/Yissum)HU-671 +[9] 
ClassificationSmall molecules
Mechanisms of ActionBone synthesis stimulants
TargetsUpdating
Therapy Area/IndicationsPrader-Willi SyndromeOsteoporosisBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYissum Research Development Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClaritas Pharmaceuticals IncYissum Research Development Company
Active IndicationsN/A
Inactive IndicationsPrader-Willi SyndromeOsteoporosisBone Diseases

Other Information

ATC CodeN/A
Related LinksN/A